Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8828001 | European Urology Focus | 2017 | 8 Pages |
Abstract
In this review, we evaluated the current status of urinary cell-free nucleic acid in genitourinary cancers. We identified the potential advantages of urinary cell-free nucleic acid over blood and urine sediment and its clinical use in genitourinary cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Selena Y. Lin, Jennifer A. Linehan, Timothy G. Wilson, Dave S.B. Hoon,